Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

DOID MESH Endpoint Browser PheWeb

E4_HYPERURI

No definition available.

Endpoint definition

↥

FinnGen phenotype data

429209 individuals

Apply sex-specific rule None

429209

Check conditions None

429209

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 E79.0

Cause of death: ICD-10 E79.0

2 out of 7 registries used, show all original rules.

133

Check minimum number of events None

133

Include endpoints None

133

Remove individuals based on genotype QC

129

E4_HYPERURI

Control definitions

Control exclude E4_METABOLIA

Extra metadata

Level in the ICD hierarchy 4

First used in FinnGen datafreeze DF2

Parent code in ICD-10 E79

Name in latin Hyperurichaemia sine symptomatibus arthritidis inflammatoriae sive morbi tophacei

NAME	E4_HYPERURI
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E790
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E790
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Show upset plot detailing case counts by codes

Or the full data table

Similar endpoints

↥

List of similar endpoints to Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	129	44	85
Unadjusted prevalence (%)	0.03	0.02	0.05
Mean age at first event (years)	64.34	62.15	65.47

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: E4_HYPERURI – Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
GWS hits:

Survival analyses between endpoints

↥

Plot

before Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
after Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

↥

Endpoint not on priority list, no data to show.

≡ Risteys

R10

R9

R8

R7

R6

R5

R4

R3